Literature DB >> 2176084

Oxidative degradation of rat mast-cell heparin proteoglycan.

D D Metcalfe1, H L Thompson, S J Klebanoff, W R Henderson.   

Abstract

The susceptibility of rat mast-cell heparin to oxidative degradation was examined. Heparin as a component of intact mast-cell granules (MCG) was degraded following ingestion by normal human neutrophils. In contrast, neutrophils from patients with chronic granulomatous disease (CGD), which do not respond to stimulation with respiratory-burst activity, exhibited a greatly diminished ability to degrade phagocytosed MCG heparin. MCG-associated heparin also was cleaved by H2O2 plus Fe2+ (Fenton's reagent). Isolated heparin proteoglycan (average Mr approx. 750,000) was rapidly cleaved to smaller molecules similar in size to commercial pig heparin upon exposure to Fenton's reagent. This cleavage was inhibited by catalase and by the hydroxyl-radical (OH.)-scavenger mannitol, but not by superoxide dismutase (SOD). The cleavage products retained approx. 26% of the anticoagulant activity of the native molecule. The heparin proteoglycan was also cleaved by acetaldehyde/xanthine oxidase/FeSO4, a system that generates superoxide (O2.-), H2O2 and OH.. Whereas the cleavage at relatively high iron ion concentrations was inhibited by catalase and mannitol but not by SOD, at lower iron ion concentrations the cleavage was inhibited by catalase, mannitol and SOD. These findings suggest the involvement of OH., which at high Fe2+ concentrations is generated by Fenton's reagent (H2O2 plus Fe2+), and at low iron ion concentrations is generated by the iron-ion-catalysed interaction between O2.- and H2O2 (Haber-Weiss reaction). These studies suggest that oxygen radicals generated by activated phagocytes may contribute to the degradation in vivo of both solubilized and granule-associated proteoglycan heparin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176084      PMCID: PMC1149655          DOI: 10.1042/bj2720051

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

1.  Depolymerization of hyaluronic acid by the ORD reaction.

Authors:  W PIGMAN; S RIZVI; H L HOLLEY
Journal:  Arthritis Rheum       Date:  1961-06

2.  Phagocytosis of granules from disrupted mast cells.

Authors:  D E SMITH; Y S LEWIS
Journal:  Anat Rec       Date:  1958-09

3.  The separation of active and inactive forms of heparin.

Authors:  L H Lam; J E Silbert; R D Rosenberg
Journal:  Biochem Biophys Res Commun       Date:  1976-03-22       Impact factor: 3.575

4.  A method for the determination of heparin in blood.

Authors:  L B JAQUES; F C MONKHOUSE; M STEWART
Journal:  J Physiol       Date:  1949-08       Impact factor: 5.182

5.  Desulphation of heparin by mice and guinea pig leukocytes.

Authors:  I Fabian; I Bleiberg; M Aronson
Journal:  Biochim Biophys Acta       Date:  1976-06-23

6.  Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates.

Authors:  H Saito; T Yamagata; S Suzuki
Journal:  J Biol Chem       Date:  1968-04-10       Impact factor: 5.157

7.  Catalytic role of copper and iron ions in the depolymerization of hyaluronic acid by ascorbic acid.

Authors:  G Matsumura; W Pigman
Journal:  Arch Biochem Biophys       Date:  1965-06       Impact factor: 4.013

8.  Analysis of proteoglycans by high-performance liquid chromatography: a rapid micromethod for the separation of proteoglycans from tissue and cell culture.

Authors:  R V Iozzo; R Marroquin; T N Wight
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

9.  Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma.

Authors:  S Ogren; U Lindahl
Journal:  J Biol Chem       Date:  1975-04-10       Impact factor: 5.157

10.  Modulation of cyclic AMP in purified rat mast cells. I. Responses to pharmacologic, metabolic, and physical stimuli.

Authors:  T J Sullivan; K L Parker; W Stenson; C W Parker
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

View more
  6 in total

Review 1.  Oxidative depolymerization of polysaccharides by reactive oxygen/nitrogen species.

Authors:  Jinyou Duan; Dennis L Kasper
Journal:  Glycobiology       Date:  2010-10-28       Impact factor: 4.313

Review 2.  Mast cells and mastocytosis.

Authors:  Dean D Metcalfe
Journal:  Blood       Date:  2008-08-15       Impact factor: 22.113

Review 3.  Small proteoglycans.

Authors:  H Kresse; H Hausser; E Schönherr
Journal:  Experientia       Date:  1993-05-15

4.  In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment.

Authors:  Sung K Chang; Imran Rizvi; Nicolas Solban; Tayyaba Hasan
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

5.  Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages.

Authors:  F T Liu; D K Hsu; R I Zuberi; I Kuwabara; E Y Chi; W R Henderson
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

Review 6.  Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase.

Authors:  Michela G Schäppi; Vincent Jaquet; Dominique C Belli; Karl-Heinz Krause
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.